Enhanced EGFR abundance and signaling in glioblastoma can occur by different mechanisms, such as alterations in genetic information (amplification of receptor, mutation, and chromosomal translocation), angiogenesis, autocrine and paracrine signaling, and epithelial–mesenchymal transition [32,33]. This evidence concerns the gene EGFR and glioblastoma.